Cite
HARVARD Citation
Cheng, L. (2019). Response to re: Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al., NBM 2019. NMR in biomedicine. p. n/a. [Online].